New hope for Crohn's scarring? early safety trial completed
Knowledge-focused
Completed
This study tested a new medicine called AGMB-129 in 30 healthy adults to see if it is safe and how the body processes it. The drug is being developed to treat scarring and blockages in the gut caused by Crohn's disease, for which there are no approved treatments yet. This early-p…
Phase: PHASE1 • Sponsor: Agomab Spain S.L.U. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC